Trial of New Alzheimer’s Drug Reports Disappointing Results
The drug, crenezumab, failed to prevent early symptoms or slow [...]
The drug, crenezumab, failed to prevent early symptoms or slow [...]
The drug company will effectively give up on marketing Aduhelm, [...]
Studies linked to Cassava Sciences, once a stock market favorite, [...]
Officials cited data showing the new Alzheimer’s drug has serious [...]
The Alzheimer’s Association has pushed relentlessly to get broad access [...]
Medicare officials are trying to determine whether to cover Aduhelm, [...]
A group of Alzheimer’s experts and health advocates called on [...]
The drug, Aduhelm, has been mired in controversy since it [...]
The drug, Aduhelm, brought in $300,000 in revenue in its [...]
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” [...]